Health Planners

This report contains CDC analysis of notifiable disease surveillance data on reported syphilis, including patient demographics and stage of syphilis as reported by health departments to the National Notifiable Diseases Surveillance System (NNDSS) for cases diagnosed during (2005-2013). Trends in annual primary and secondary syphilis were analyzed for 2005-2013; geographic trends were analyzed by US census region, age group, and NNDSS racial/ethnic categories.

The State HIV Prevention Progress Report (SPR) provides state-level data that show how states are doing in relation to key national goals. The report monitors HIV outcomes at the state population level but does not specifically evaluate CDC-funded activities. For 3 indicators (HIV testing, late-stage diagnosis, and death rate), the report includes data on all 50 states and the District of Columbia.

This report focuses on the social determinants of health (SDH) and its crossover to HIV rates in the United States. It explains that SDH refers to the overlapping social structures and economic systems that are responsible for most health inequities. Twelve tables break down rates of HIV diagnoses by indicators such as sex, age, area of residence, race, and transmission category. This report limits the data to adults older 18 and older to more accurately represent the population from which the SDH indicator variables were collected by the US Census Bureau’s American Community Survey (ACS).

This report describes novel HIV screening programs at the Urban Health Plan (UHP), Inc. in New York City and the Interim Louisiana Hospital (ILH) emergency department in New Orleans. Both received startup funding from Gilead Sciences’ HIV on the Frontlines of Communities in the United States (FOCUS) program to implement routine HIV screening. Both programs identified previously undiagnosed HIV infections. Use of the new testing algorithm allowed the New Orleans program to identify antibody-negative acute infections in five (6%) of the 77 patients with newly diagnosed HIV.

To assess progress with HPV vaccination coverage among adolescents aged 13–17 years, characterize adherence with recommendations for HPV vaccination by the 13th birthday, and describe HPV vaccine adverse reports received postlicensure, CDC analyzed data from the 2007–2013 National Immunization Survey-Teen (NIS-Teen) and national postlicensure vaccine safety data among females and males. Vaccination coverage with =1 dose of any HPV vaccine increased significantly from 53.8% (2012) to 57.3% (2013) among adolescent girls and from 20.8% (2012) to 34.6% (2013) among adolescent boys.

This report describes a case of HIV transmission through sexual contact between an infected woman and her previously uninfected female sex partner. The Houston Department of Health reported the case to CDC in August 2012. The case was investigated and laboratory testing confirmed that the virus that infected the newly-diagnosed woman was identical to that of her female partner who had stopped receiving antiretroviral therapy in 2010. The report describes the case of HIV infection acquired during a six-month monogamous relationship.

This information sheet discusses the relationship between intimate partner violence (IPV) and HIV in women. It uses data from the 2010 National Intimate Partner and Sexual Violence Survey to show the number of women who have experienced IPV, explains the links between IPV and HIV, provides studies which suggest that IPV can be a risk factor and a consequence of HIV as well as studies of women with a history of abuse.

This information sheet provides tips for creating educational chlamydia-screening materials and products for young women. The research was based on data from focus groups. A total of 18 focus groups and one dyad were conducted in four cities across the United States including three segments of sexually active females ages 15-25 years.